• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  11/10/2011
Trade Name:  HEMACORD
Generic or Proper Name (*):  hematopoietic progenitor cells, cord blood*
Indications Studied:  For use in unrelated donor hematopoietic progenitor cell transplantation procedures in conjunction with an appropriate preparative regimen for hematopoietic and immunologic reconstitution in patients with disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
Therapeutic Category:  Somatic Cell
Ages Studied:  2 months - 72 years
Study #:  3
Study Type:  Efficacy/Safety
Study Design:  Retrospective
No Patients:  155
No Centers:  Multi
No Countries:  International
Asian:  0
Black:  0
Other:  0
White:  0
Unknown:  0
Native Hawaiian or Pacific Islander:  0
American Indian/Alaska Native:  0
Hispanic/Latino:  0
Non-Hispanic/Non Latino:  0
Countries:  NA